Mereo BioPharma Group PLC (MREO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | ||||||||
|---|---|---|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | ||||||||
| Total Current Assets | ||||||||
| Cash and Equivalents | ||||||||
| Total Non-Current Assets | ||||||||
| Total Liabilities | ||||||||
| Total Current Liabilities | ||||||||
| Total Non-Current Liabilities | ||||||||
| Common Equity | ||||||||
| Retained Earnings |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 86.77M | 96.34M | 67.28M | 86.45M | 62.95M | 126.42M | 84.12M | 62.5M |
| Total Current Assets | 60.78M | 63.18M | 34.5M | 30.44M | 29.73M | 99.32M | 62.13M | 50.08M |
| Cash and Equivalents | 53.58M | 50.05M | 25.04M | 16.35M | 23.47M | 94.3M | 56.33M | 45.1M |
| Total Non-Current Assets | 79.26M | 62.48M | 32.77M | 40.26M | -14.97M | 88M | 62.54M | 49.31M |
| Total Liabilities | 7.51M | 33.85M | 34.51M | 46.19M | 77.92M | 38.42M | 21.58M | 13.19M |
| Total Current Liabilities | 3.21M | 9.62M | 16.18M | 29.88M | 8.57M | 12.54M | 20.23M | 7.64M |
| Total Non-Current Liabilities | 7.43M | 43.05M | 32.97M | 31.01M | 86.65M | 42.01M | 2.57M | 10.18M |
| Total Equity | 79.26M | 62.48M | 32.77M | 40.26M | -14.97M | 88M | 62.54M | 49.31M |
| Common Equity | 193k | 213k | 214k | 294k | 1.02M | 1.76M | 1.88M | 2.1M |
| Retained Earnings | -33.58M | -79.32M | -111.22M | -146.07M | -309.69M | -296.97M | -329.16M | -362.34M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
